jCyte Announces Appointment of John Sholar as General Counsel
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc., a biotech company dedicated to improving the lives of patients with retinal degenerative diseases, today announced the further expansion of the company’s executive management team with the appointment of John Sholar as General Counsel. Mr. Sholar brings to jCyte more than 20 years of industry experience, serving as the head of North American legal for a large publicly traded pharmaceutical company, in private practice as a law firm partner fo